Barclays’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17B | Sell |
|
|||||
|
2025
Q1 | $1.47B | Buy |
|
|||||
|
2024
Q4 | $1.21B | Buy |
|
|||||
|
2024
Q3 | $1.38B | Sell |
|
|||||
|
2024
Q2 | $1.87B | Sell |
|
|||||
|
2024
Q1 | $1.64B | Sell |
|
|||||
|
2023
Q4 | $1.51B | Buy |
|
|||||
|
2023
Q3 | $1.11B | Buy |
|
|||||
|
2023
Q2 | $711M | Buy |
|
|||||
|
2023
Q1 | $209M | Sell |
|
|||||
|
2022
Q4 | $556M | Buy |
|
|||||
|
2022
Q3 | $373M | Buy |
|
|||||
|
2022
Q2 | $270M | Sell |
|
|||||
|
2022
Q1 | $340M | Sell |
|
|||||
|
2021
Q4 | $766M | Buy |
|
|||||
|
2021
Q3 | $438M | Buy |
|
|||||
|
2021
Q2 | $276M | Buy |
|
|||||
|
2021
Q1 | $198M | Buy |
|
|||||
|
2020
Q4 | $144M | Buy |
|
|||||
|
2020
Q3 | $123M | Buy |
|
|||||
|
2020
Q2 | $101M | Sell |
|
|||||
|
2020
Q1 | $110M | Sell |
|
|||||
|
2019
Q4 | $178M | Sell |
|
|||||
|
2019
Q3 | $169M | Sell |
|
|||||
|
2019
Q2 | $179M | Buy |
|
|||||
|
2019
Q1 | $160M | Buy |
|
|||||
|
2018
Q4 | $120M | Sell |
|
|||||
|
2018
Q3 | $146M | Buy |
|
|||||
|
2018
Q2 | $109M | Sell |
|
|||||
|
2018
Q1 | $119M | Buy |
|
|||||
|
2017
Q4 | $94M | Buy |
|
|||||
|
2017
Q3 | $47.1M | Buy |
|
|||||
|
2017
Q2 | $41.9M | Sell |
|
|||||
|
2017
Q1 | $90.7M | Buy |
|
|||||
|
2016
Q4 | $56M | Sell |
|
|||||
|
2016
Q3 | $115M | Buy |
|
|||||
|
2016
Q2 | $49.7M | Buy |
|
|||||
|
2016
Q1 | $44.5M | Sell |
|
|||||
|
2015
Q4 | $53.8M | Sell |
|
|||||
|
2015
Q3 | $60.3M | Sell |
|
|||||
|
2015
Q2 | $92.7M | Sell |
|
|||||
|
2015
Q1 | $108M | Buy |
|
|||||
|
2014
Q4 | $98.2M | Buy |
|
|||||
|
2014
Q3 | $81.3M | Sell |
|
|||||
|
2014
Q2 | $82.8M | Sell |
|
|||||
|
2014
Q1 | $84.6M | Sell |
|
|||||
|
2013
Q4 | $95.4M | Buy |
|
|||||
|
2013
Q3 | $90.4M | Buy |
|
|||||
|
2013
Q2 | $80M | Buy |
|